University of Michigan labs are using advanced technology to help people like quadriplegics and amputees lead fuller lives ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

Cardiac electrophysiologist Dr. Jonathan Piccini says Medtronic's Define AFib study offers important lessons for other device ...

Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All participants with disease control experienced ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Black patients show higher clinical trial interest with Black researchers. Learn how representation matters in medical ...

The following is a summary of "Redefining Clinical Trial Strategic Design to Support Drug Approval in Medical Oncology” ...

Medtronic’s VenaSeal Spectrum postmarket clinical trial program is highlighting the need for further patient-centric ...

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

CHWs bridge gaps in asthma care for Black children. Study shows promise in improving outcomes & clinical trial participation.

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...